Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2008
11/26/2008CN101312977A Fused heterocyclic compounds useful as kinase modulators
11/26/2008CN101312976A Spirocyclic compounds as hdac inhibitors
11/26/2008CN101312972A Bicyclic cinnamide compound
11/26/2008CN101312966A Benzothiazole cyclobutyl amine derivatives and their use as histamine-3 receptors ligands
11/26/2008CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/25/2008US7456567 organic electroluminescent device having a pair of electrodes, and at least one organic layer interposed between the pair of electrodes, with the organic layer containing at least one compound represented by formula (1):** Image-1
11/25/2008US7456294 Hairpin polyamide
11/25/2008US7456291 Use of a vitamin combination for the treatment of primary headaches
11/25/2008US7456288 Heterocyclic compounds and methods of making and using thereof
11/25/2008US7456206 Biaryl heterocyclic compounds and methods of making and using the same
11/25/2008US7456203 for treatment/prevention of chronic obstructive pulmonary disease, chronic bronchitis, irritable bowel syndrome, and urinary incontinence
11/25/2008US7456193 Disorders of GABAergic transmission associated with GABAA receptor subtypes, such as anxiety, sleep disorders, epilepsy; 1,6-dimethyl-3-(pyridin-4-yl)-1,9-dihydro-2H-pyrido[2,3-b]indol-2-one
11/25/2008US7456186 Diphenylimidazopyrimidines as inhibitors of β-secretase
11/25/2008US7456183 Melanocortin-4 receptor agonists; obesity, type II diabetes; such as N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-(2,6,6-trimethylbicyclo(3.1.1)hept-3yl)piperazine-1-carboximidamide
11/25/2008US7456178 Compounds, methods and pharmaceutical compositions for inhibiting PARP
11/25/2008US7456173 Compositions comprising zopiclone derivatives and methods of making and using the same
11/25/2008US7456171 Nicotinic ligands; treatment of nervous system disorders, neurodegenerative disorders, psychological disorders, and tobacco, drug and alcohol withdrawal symptoms
11/25/2008US7456170 Triazolobenzodiazepines and their use as vasopressin antagonists
11/25/2008US7455917 Organic compound and organic light emitting device using the same
11/25/2008CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/25/2008CA2382588C Polymorphs of n-methyl-n-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-.alpha.]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
11/25/2008CA2342830C 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
11/20/2008WO2008141249A1 Imidazol (1,2-a)pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141239A1 Imidazol [1,2-a] pyridines and related compounds with activity at cannabinoid cb2 receptors
11/20/2008WO2008141145A1 Condensed heterocyclic compounds as inhibitors of protein kinases
11/20/2008WO2008141140A1 Condensed heterocyclic compounds as inhibitors of protein kinases
11/20/2008WO2008141021A1 Deuterated derivatives of tetrahydrotriazolopyrazine compounds and their use as dpp-iv inhibitors
11/20/2008WO2008140947A1 P70 s6 kinase inhibitors
11/20/2008WO2008139576A1 Method for producing lactam compound and production intermediate thereof
11/20/2008WO2008139574A1 Crystalline form of lactam compound and process for producing the same
11/20/2008WO2008139293A1 Amino-heterocyclic compounds
11/20/2008WO2008138889A2 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors
11/20/2008WO2008138843A1 Imidazopyridines and triazolopyrimidines useful for the treatment of joint degenerative & inflammatory diseases
11/20/2008WO2008138842A1 Imidazopyrazines and triazolopyrazine for the treatment of joint degenerative and inflammatory diseases
11/20/2008WO2008138834A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/20/2008WO2008138551A2 3-(2-alkoxy-phenyl)-substituted tetramates
11/20/2008WO2008138232A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008WO2008138184A1 Derivatives of pyrroloazacycles, the method of making them and the use thereof as inhibitors of protein kinases
11/20/2008WO2008117225A3 New imidazolo-heteroaryl derivatives with antibacterial properties
11/20/2008WO2008070313A3 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/20/2008WO2008027812A3 Imidazopyridine and imidazopyrimidine derivatives
11/20/2008WO2007131168A3 Inhibitors of secretion of hepatitis b virus antigens for treatment of a chronic hepatitis virus
11/20/2008WO2007109661A3 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities
11/20/2008US20080287689 Heat-stable diketopyrrolopyrrole pigment mixtures
11/20/2008US20080287478 Nociceptin Analogues and Uses Thereof
11/20/2008US20080287463 Pyrazolopyrimidines
11/20/2008US20080287457 Inhibitors of Akt Activity
11/20/2008US20080287454 Cxcr4 antagonists
11/20/2008US20080287450 Novel Substituted Tetracyclic Tetahydrofuran, Pyrrolidine And Tetrahydrothiophene Derivatives
11/20/2008US20080287448 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287430 Furan Compounds Useful As Ep1 Receptor Antagonists
11/20/2008US20080287423 Antidiabetic agents; neurodegenerative disorders; mixture with immunosuppresants
11/20/2008US20080287422 [9-(2,2-Dimethyl-propyl)-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(S)-cyclohepta[e]inden-7-yl]-acetic acid methyl ester; calcitonin gene-related peptide (CGRP) receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, circulatory shock, menopause, asthma
11/20/2008US20080287421 3,3-spiroindolinone derivatives
11/20/2008US20080287416 Organic Compounds
11/20/2008US20080287397 Pyrrolopyrimidine Derivatives Substituted with Cyclic Amino Group
11/20/2008US20080287394 hydroxy-substituted pyrazinopyrrolopyridazine dione compounds; viricide; infection by HIV, AIDS; with other HIV/AIDS antivirals, immunomodulators, antibiotics or vaccines; 2-(2-fluorobenzyl)-10-hydroxy-4,8-dimethyl-7,8-dihydropyrazino[1',2':1,5]-pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-dione
11/20/2008US20080286233 Piperizinyl macrocyclic hepatitis c serine protease inhibitors
11/20/2008CA2686903A1 Substituted imidazopyridazines and pyrrolopyrimidines as lipid kinase inhibitors
11/20/2008CA2685757A1 Pyrrolo-nitrogenous heterocyclic derivatives, the preparation and the pharmaceutical use thereof
11/20/2008CA2685351A1 Inhibitors of protein kinases
11/20/2008CA2684932A1 Substituted imidazopyridazines as pi3k lipid kinase inhibitors
11/19/2008EP1992627A1 New water soluble porphylleren compounds
11/19/2008EP1992614A1 3-(2-Alkoxy-phenyl)-substituted tetramates
11/19/2008EP1992348A1 Pharmaceutical combination
11/19/2008EP1991549A1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
11/19/2008EP1991548A1 Salt of cd 80 antagonist
11/19/2008EP1991545A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
11/19/2008EP1991223A1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
11/19/2008CN101309976A High-purity texaphyrin metallic complex
11/19/2008CN101309922A Amino-aza-adamantane derivatives and methods of use
11/19/2008CN101307055A New water soluble porphylleren compounds
11/19/2008CN101307054A Method for preparing symmetrical N,Ní»-1-4-dialkyl triethylene diammonium tetrafluoroborate
11/19/2008CN101307053A Method for preparing antisymmetric N,Ní»-1-4-dialkyl triethylene diammonium tetrafluoroborate
11/19/2008CN101307052A Method for preparing pyrrole-N-heterocyclic ring derivates and medical application thereof
11/19/2008CN100434420C Compound inhibiting dipeptidyl peptidase iv
11/18/2008US7452998 preparing an optically pure proton pump inhibitor having a sulfinyl structure using a chiral zirconium complex or a chiral hafnium complex; comprising oxidizing a corresponding sulfide
11/18/2008US7452911 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
11/18/2008US7452905 Phenylalanine derivatives
11/18/2008US7452897 Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases
11/18/2008US7452893 4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists
11/18/2008US7452892 2-substituted 7-aryl-[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one; mitogen-activated protein kinase inhibitor; physiological and psychotropic effects including regulation of appetite, immunosuppression, analgesia, inflammation, emesis, anti-nocioception, sedation, and intraocular pressure
11/18/2008US7452888 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders
11/18/2008US7452886 E.g., 6-(6-Chloro-pyridin-3-yloxymethyl)-7-(2,2-dimethyl-propyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; in particular, cathepsin K inhibitors; osteoporosis; oral, autoimmune and respiratory diseases; osteoarthritis; antiarthritic and antitumor agents; muscular dystrophy; amytrophy; parasiticides
11/18/2008US7452880 p38 kinase inhibitors; arthritis, Crohn's disease, irritable bowel syndrome, adult respiratory distress syndrome, or chronic obstructive pulmonary disease; pyrazolo(3,4-d)pyrimidines
11/18/2008US7452641 Electrophotographic organophotoreceptors with novel charge transport compounds
11/18/2008US7452385 Naphthalene derivatives and colorants for keratin fibers containing these compounds
11/18/2008CA2523831C 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
11/18/2008CA2516557C Triazole compounds useful in therapy
11/18/2008CA2422379C Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/13/2008WO2008137779A2 Novel macrocyclic inhibitors of hepatitis c virus replication
11/13/2008WO2008137436A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
11/13/2008WO2008136948A1 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as p38 modulators, process for their preparation, and their pharmaceutical use
11/13/2008WO2008136756A1 Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
11/13/2008WO2008136406A1 Method and apparatus for production of crude phthalocyanine pigment product
11/13/2008WO2008136394A1 Method for production of lactam compound, and intermediate for the production method
11/13/2008WO2008136393A1 Crystal of lactam compound, and method for production thereof
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 573